Skip to content
AnalystLens
Back to HALOIncome Statement

Halozyme Therapeutics Revenue 2009-2026 | HALO

Annual FY2009–FY2025 · quarterly through Q3 FY2026

Latest annual · FY2025

$1.40B

+37.6%YoY vs FY2024Source: 10-KFY2025

From $13.7M in FY2009 to $1.40B in FY2025: 102.2× in 16 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$377M+42.2%$481M+47.7%$493M+39.2%Not reported
FY25$265M+35.2%$326M+40.8%$354M+22.1%$452M+51.6%
FY24$196M+20.8%$231M+4.7%$290M+34.3%$298M+29.5%
FY23$162M+38.3%$221M+45.1%$216M+3.4%$230M+26.7%
FY22$117M+31.7%$152M+11.7%$209M+80.4%$181M+77.9%
Share19%24%27%30%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date. Share: its typical part of the fiscal year.

Key Statistics

Trend DirectionGrowing
CAGR

+39.2%

FY2020
$267.6M
FY2025
$1.40B

5 years selected · on the chart

Revenue History

Year-over-year comparison from 10-K annual reports

  1. $1.40B
YoY changeLargest recent move+115.8%in FY17Latest +37.6%

1 older move runs past ±150% (largest +311.7%); point at, tap or drag across the bars to read one.

Revenue, period by period

PeriodValueChangeSource
FY2025$1.40B+37.6%10-K
FY2024$1.02B+22.4%10-K
FY2023$829.3M+25.6%10-K
FY2022$660.1M+48.9%10-K
FY2021$443.3M+65.7%10-K
FY2020$267.6M+36.5%10-K
FY2019$196.0M+29.1%10-K
FY2018$151.9M−52.0%10-K
FY2017$316.6M+115.8%10-K
FY2016$146.7M+8.6%10-K
FY2015$135.1M+79.3%10-K
FY2014$75.3M+37.5%10-K
FY2013$54.8M+29.5%10-K
FY2012$42.3M−24.5%10-K
FY2011$56.1M+311.7%10-K
FY2010$13.6M−0.3%10-K
FY2009$13.7M—10-K

What is revenue?

Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

What is Halozyme Therapeutics's current revenue?

Halozyme Therapeutics (HALO) annual revenue for 2025 was $1.40B, a 37.55% increase from 2024. Halozyme Therapeutics revenue for the quarter ending September 30, 2026 was $493.0M.

What was Halozyme Therapeutics's revenue in 2024?

Halozyme Therapeutics annual revenue for 2024 was $1.02B, a 22.44% increase from 2023.

What was Halozyme Therapeutics's revenue in 2023?

Halozyme Therapeutics annual revenue for 2023 was $829.3M, a 25.62% increase from 2022.

What is Halozyme Therapeutics's 5-year revenue CAGR?

Halozyme Therapeutics revenue grew at a compound annual growth rate (CAGR) of 39.16% from FY2020 to FY2025, going from $267.6M to $1.40B over 5 years.

Company
Halozyme Therapeutics
Ticker
HALO
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)